Sign in
4

Changes in Ownership

NextCure, Inc. Filed Acc 0001123292-20-000457

Options or other derivatives

  • President & CEO acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Richman Michael · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-28 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +225,000 225,000 D
Loading xslF345X03/edgar.xml…